Authors: Kumar, V Marella, MA Cortes-Burgos, L Chang, AC Cassel, JA Daubert, JD DeHaven, RN DeHaven-Hudkins, DL Gottshall, SL Mansson, E Maycock, AL

Citation: V. Kumar et al., Arylacetamides as peripherally restricted kappa opioid receptor agonists, BIOORG MED, 10(22), 2000, pp. 2567-2570

Authors: Schlechtingen, G Zhang, L Maycock, A DeHaven, RN Daubert, JD Cassel, J Chung, NN Schiller, PW Goodman, M

Citation: G. Schlechtingen et al., [Pro(3)]Dyn A(1-11)-NH2: A dynorphin analogue with high selectivity for the kappa opioid receptor, J MED CHEM, 43(14), 2000, pp. 2698-2702

Authors: Machelska, H Pfluger, M Weber, W Piranvisseh-Volk, M Daubert, JD Dehaven, R Stein, C

Citation: H. Machelska et al., Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans, J PHARM EXP, 290(1), 1999, pp. 354-361

Authors: Dehaven-Hudkins, DL Burgos, LC Cassel, JA Daubert, JD Dehaven, RN Mansson, E Nagasaka, H Yu, G Yaksh, T

Citation: Dl. Dehaven-hudkins et al., Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity, J PHARM EXP, 289(1), 1999, pp. 494-502